EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Promoter‐Targeting RNA Technologies: An Epigenetic Strategy for Gene Activation and Gene Silencing

Rajat Hegde iD, Maryam Abdul Ajees, Kedlaya Srikrishna H Damodar, Esha Poojary, Smita Hegde, Shama Prasada Kabekkodu iD

WIREs RNA · 2026-05 · 17 (3)

DOI: 10.1002/wrna.70043 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift WIREs RNA, online erschienen am 03.05.2026. Verfasst von Rajat Hegde und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell and Molecular Biology, Manipal School of Life Sciences, Manipal Academy of Higher Education, Manipal, India. Hauptthemen laut MEDLINE: Gene Silencing, Promoter Regions, Genetic, Epigenesis, Genetic, RNA. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 111 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Promoter‐targeted RNAs (PTRs) are emerging as a transformative approach for future therapeutics, offering the ability to directly modulate gene expression at the transcriptional level. Unlike traditional RNA‐based methods that work post transcriptionally, PTRs interact with gene promoter regions to either activate or suppress gene transcription. This strategy offers a key advantage by enabling more stable and long‐lasting control of gene expression, since it acts directly at the level of chromatin and epigenetic regulation rather than only degrading RNA or blocking translation. Unlike CRISPR‐based methods, promoter‐targeted RNAs alongside traditional siRNAs and ASOs provide a reversible and finely tuned way to reprogram the chromatin accessibility and histone modifications without making permanent changes to the genome. This review explores the broadening spectrum of PTRs modalities, including small activating RNAs, small interfering RNAs, promoter‐targeted R‐loop inducers, peptide nucleic acids, RNA aptamers, and triplex‐forming RNAs. Several preclinical studies have demonstrated their ability to reactivate silenced tumor suppressor genes or downregulate oncogenes, offering targeted and reversible gene control. Notably, saRNAs like MTL‐CEBPA (Phase II) and RAG‐01 (Phase I) have reached clinical evaluation for liver and bladder cancer, highlighting their translational potential. However, efficient nuclear delivery, off‐target effects, immune activation, and tumor heterogeneity remain the major concerns for clinical applications. Future progress in this field will depend on overcoming technical hurdles such as ensuring efficient nuclear delivery, improving chemical modifications to increase RNA stability, and designing delivery systems that combine tissue‐specific targeting with precise transcriptional regulation. This article is categorized under: Regulatory RNAs/RNAi/Riboswitches > Regulatory RNAs Regulatory RNAs/RNAi/Riboswitches > RNAi: Mechanisms of Action Regulatory RNAs/RNAi/Riboswitches > Biogenesis of Effector Small RNAs

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gene SilencingPromoter Regions, GeneticEpigenesis, GeneticRNAHumansAnimalsRNA, Small Interfering

Stichwörter der Autor:innen

promoter‐targeted RNAspromoter‐targeted peptide nucleic acidspromoter‐targeted triplex‐forming RNAssmall activating RNAssmall interfering RNAs

Substanzen

RNARNA, Small Interfering

Autor:innen und Institutionen

  • Department of Cell and Molecular Biology, Manipal School of Life Sciences, Manipal Academy of Higher Education, Manipal, India.
  • Department of Public Health Genomics, Manipal School of Life Sciences, Manipal Academy of Higher Education, Manipal, India.
  • Department of Nuclear Medicine, Manipal College of Health Professions, Manipal Academy of Higher Education, Manipal, India.

ORCID-Profile: Rajat Hegde, Shama Prasada Kabekkodu

Zitieren

APA

Hegde, R., Ajees, M. A., Damodar, K. S. H., Poojary, E., Hegde, S., & Kabekkodu, S. P. (2026). Promoter‐Targeting RNA Technologies: An Epigenetic Strategy for Gene Activation and Gene Silencing. WIREs RNA, 17(3). https://doi.org/10.1002/wrna.70043

Vancouver

Hegde R, Ajees MA, Damodar KSH, Poojary E, Hegde S, Kabekkodu SP. Promoter‐Targeting RNA Technologies: An Epigenetic Strategy for Gene Activation and Gene Silencing. WIREs RNA. 2026;17(3). doi:10.1002/wrna.70043

BibTeX
@article{Hegde2026,
  author = {Hegde, Rajat and Ajees, Maryam Abdul and Damodar, Kedlaya Srikrishna H and Poojary, Esha and Hegde, Smita and Kabekkodu, Shama Prasada},
  title = {Promoter‐Targeting RNA Technologies: An Epigenetic Strategy for Gene Activation and Gene Silencing},
  journal = {WIREs RNA},
  year = {2026},
  volume = {17},
  number = {3},
  doi = {10.1002/wrna.70043}
}
Kostenlos starten →